Psychological adjustment in patients with an implantable cardioverter defibrillator primary prevention and secondary prevention. A comparative study

被引:0
|
作者
Alcaraz Andreu, Silvia [1 ]
Hidalgo Montesinos, Maria Dolores [2 ]
Godoy Fernandez, Carmen [3 ]
Fernandez Ros, Encarna [3 ]
Sanchez Munoz, Juan Jose [4 ]
Garcia Alberola, Arcadio [4 ]
机构
[1] Univ Murcia, Fac Psicol, Escuela Int Doctorado, Murcia, Spain
[2] Univ Murcia, Dept Psicol Basicas & Metodol, Murcia, Spain
[3] Univ Murcia, Dept Personalidad Evaluac & Tratamientos Psicol, Murcia, Spain
[4] Hosp Clin Univ Virgen de la Arrixaca, IMIB, Unidad Arritmias Serv Cardiol, Murcia, Spain
来源
REVISTA ESPANOLA DE SALUD PUBLICA | 2020年 / 94卷
关键词
Psychological adjustment; Implantable cardioverter defibrillator; Primary prevention; Secondary prevention; ANXIETY; DEPRESSION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The implantation of the Implantable Cardioverter Defibrillator (ICD) influences the psychological adjustment and the degree of subjective discomfort. The objective of this work was to analyze differences in psychological adjustment. fear of shocks and the degree of subjective discomfort derived from the illness depending on the reasons for implantation (primary vs secondary). Methods: A sample of 82 patients with an ICD. for primary (58.5%) or secondary (41.5%) prevention indications was studied. A sociodemographic and clinical questionnaire and List of Brief Symptoms (LBS-50) was used. Descriptive univariate and bivariate analysis, t-tests on mean differences for independent samples and z-tests on proportion differences were performed. Results: Regarding psychological adjustment. 43.9% of the patients reported to have sleeping disorder, regardless the type of prevention. A greater percentage of patients of primary prevention had scored higher in clinical scales. The 29.4% of patients with secondary prevention reported to be afraid of experiencing some shock. The 25% of patients whose type of prevention was primary showed severe or moderate level of subjective discomfort derived from the illness compared with the 14.7% of the secondary prevention patients (p=0.7). Conclusions: The patients with an ICD show symptoms clinically significant in Psychoactivity, Obsession-Compulsion, Anxiety, Somatization, Sleeping disorders and Psychopathology Risk Index. Both groups, regardless the type of prevention showed a similar psychological adjustment. Regarding the fear of shocks and the degree of subjective discomfort derived from the illness, no statistically significant differences between the groups were found.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Syncope in Primary Prevention Implantable Cardioverter Defibrillator Patients
    Goldenberg, Gustavo
    Bental, Tamir
    Kadmon, Udi
    Zabarsky, Ronit
    Kusnick, Jairo
    Barsheshet, Mon
    Golovchiner, Gregory
    Strasberg, Boris
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2016, 18 (06): : 318 - 321
  • [2] Workforce affiliation in primary and secondary prevention implantable cardioverter defibrillator patients: a nationwide Danish study
    Rosenkranz, Simone H.
    Wichmand, Charlotte H.
    Smedegaard, Laerke
    Moller, Sidsel
    Bjerre, Jenny
    Schou, Morten
    Torp-Pedersen, Christian
    Philbert, Berit T.
    Larroude, Charlotte
    Melchior, Thomas M.
    Nielsen, Jens C.
    Johansen, Jens B.
    Riahi, Sam
    Holmberg, Teresa
    Gislason, Gunnar
    Ruwald, Anne-Christine
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2023, 10 (04) : 314 - 325
  • [3] Defibrillation Threshold Testing Should Not Be Abandoned in Patients Receiving an Implantable Cardioverter Defibrillator for Primary Prevention.
    Tanawuttiwat, Tanyanan
    Bhan, Adarsh
    Harindhanavudhi, Tasma
    Duggal, Manoj
    Silver, Marc A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A133 - A133
  • [4] Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention
    Thuraiaiyah, Jani
    Philbert, Berit Thornvig
    Jensen, Annette Schophuus
    Xing, Lucas Yixi
    Joergensen, Troels Hoejsgaard
    Lim, Chee Woon
    Jakobsen, Frederikke Noerregaard
    Baekke, Pernille Steen
    Schmidt, Michael Rahbek
    Idorn, Lars
    Holdgaard Smerup, Morten
    Johansen, Jens Brock
    Riahi, Sam
    Nielsen, Jens Cosedis
    De Backer, Ole
    Sondergaard, Lars
    Jons, Christian
    EUROPACE, 2024, 26 (09):
  • [5] The comparative efficacy of implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death
    Bokhari, F
    Newman, D
    Chow, C
    Greene, M
    Edwards, J
    Dorian, P
    EUROPEAN HEART JOURNAL, 2002, 23 : 8 - 8
  • [6] Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients
    You Zhou
    Shuang Zhao
    Keping Chen
    Wei Hua
    Yangang Su
    Silin Chen
    Zhaoguang Liang
    Wei Xu
    Shu Zhang
    BMC Cardiovascular Disorders, 19
  • [7] Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients
    Zhou, You
    Zhao, Shuang
    Chen, Keping
    Hu, Wei
    Su, Yangang
    Chen, Silin
    Liang, Zhaoguang
    Xu, Wei
    Zhang, Shu
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (01)
  • [8] Predictor of wasted implantable cardioverter defibrillator for secondary prevention
    Akagawa, R.
    Otsuki, S.
    Wada, R.
    Suzuki, N.
    Ikami, Y.
    Hasegawa, Y.
    Chinushi, M.
    Inomata, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [9] Predictor of wasted implantable cardioverter defibrillator for secondary prevention
    Akagawa, R.
    Otsuki, S.
    Wada, R.
    Suzuki, N.
    Ikami, Y.
    Hasegawa, Y.
    Chinushi, M.
    Inomata, T.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [10] Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
    Reinder Evertz
    Tessa van der Heijden
    Rypko Beukema
    Sjoerd Westra
    Esther Meindersma
    Caroline van Deursen
    Kevin Vernooy
    Netherlands Heart Journal, 2023, 31 : 348 - 356